Hospital Sanitas CIMA

Recent papers from Hospital Sanitas CIMA

1. Clinical features, genotypes, and geographic distribution of 238 Latin American CGD patients2025
2. Out of hospital cardiac arrest, first steps to know and follow in Mexico to have cardioprotected territories. A point of view of a group of expertsArchivos de cardiolog�a de M�xico (English ed Internet) · 2024
3. Atypical posterior reversible encephalopathy syndrome: A lentiform fork sign following transplantationClinical Case Reports · 2024
4. Pos1237 Peripheral Nervous System Involvement of Sjögren Disease: Characterization at the Time of Diagnosis in 16,703 Patients From the Sjögren Big Data RegistryAnnals of the Rheumatic Diseases · 2024
5. Pos1247 Characterization of 284 Patients Presenting With Central Nervous System Involvement at Diagnosis of Sjögren Disease: Results From the Sjögren Big Data RegistryAnnals of the Rheumatic Diseases · 2024
6. Ab0788 Coexistence of Sarcoidosis and Spondyloarthritis: A Rare and Intriguing AssociationAnnals of the Rheumatic Diseases · 2024
7. Temporal relationship between sarcoidosis and malignancies in a nationwide cohort of 1942 patientsPostgraduate Medical Journal · 2024
8. Ventilator-associated events: From surveillance to optimizing managementJournal of Intensive Medicine · 2022
9. Heart Failure During the COVID-19 Pandemic: Clinical, Diagnostic, Management, and Organizational DilemmasESC Heart Failure · 2022
10. Diffuse Pontine Intrinsic Gliomas: First Registry Effort in Mexico2022
11. Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinionFrontiers in Cellular and Infection Microbiology · 2022
12. Characterization and outcomes of 414 patients with primary SS who developed haematological malignanciesLara D. Veeken · 2022
13. Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.2021
14. Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data ConsortiumClinical and Experimental Rheumatology · 2021
15. Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infectionClinical and Experimental Rheumatology · 2021
16. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillationBMC Cardiovascular Disorders · 2021
17. An update of targeted therapeutic options for primary Sjögren syndrome: current status and future developmentExpert Opinion on Pharmacotherapy · 2021
18. Clinical characterization and outcomes of 85 patients with neurosarcoidosisScientific Reports · 2021
19. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patientsJoint Bone Spine · 2021
20. Characterization and Outcomes of SARS-CoV-2 Infection in Patients with SarcoidosisViruses · 2021